About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Pyrophosphate and Arterial Calcification in Chronic Kidney Disease

NCT04950439·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Centre Hospitalier Universitaire de Nice

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

eGFR between 59 et 20 ml/min/1,73 m2 twice at three month interval

You may not be if

1. kidney transplantation
2. acute inflammatory disease or active cancer

The record

StatusActive not recruiting

PhaseNo phase

Taking part242

StartedMar 2022

UpdatedSep 29, 2026

Conditions

Chronic Kidney Diseases

Where1

CHU de Nice
Nice, Alpes Maritimes, France

Clareo Health | Pyrophosphate and Arterial Calcification in Chronic Kidney Disease